CPH:CC News and Press, Cipher Pharmaceuticals Inc. From 03/27/25

2025-03-27 20:45:00 ET Investing in the healthcare sector offers a unique blend of stability and growth potential. If you’re considering allocating $4,000 into healthcare stocks with strong market capitalizations on the TSX , here are four noteworthy companies to consider fir...

Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results Canada NewsWire (All figures are presented in U.S. Dollars) Generated $8.3 million in cash during Q4 2024 Natroba ™ revenue was $12.0 million for the 5 months of fiscal 20...

Firm Capital Property Trust (FCD.UN:CA) is expected to report for quarter end 2024-12-31 Alimentation Couche-Tard Inc. (ATD:CA) is expected to report $0.95 for Q3 2025 American Hotel Income Properties REIT LP (HOT.UN:CA) is expected to report for Q4 2024 Golden Minerals Company (AUMN:...

2025-03-13 11:45:00 ET Investing in quality growth stocks is a proven strategy for building long-term wealth. While growth stocks deliver outsized gains during bull markets, they also trail the broader indices by a broader margin when sentiment turns bearish. So, it’s essential to id...

Sparta Capital Ltd. (SAY:CA) is expected to report for quarter end 2024-12-31 BioSyent Inc. (RX:CA) is expected to report $0.15 for Q4 2024 Headwater Exploration Inc. (HWX:CA) is expected to report $0.2 for Q4 2024 Enterprise Group Inc. (E:CA) is expected to report for Q4 2024 Den...

Cipher Pharmaceuticals Schedules Q4 & Fiscal 2024 Earnings Release and Conference Call Cipher Pharmaceuticals Schedules Q4 & Fiscal 2024 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , March 11, 2025 /CNW/ - Cipher Pharmaceutica...

2025-01-31 16:20:00 ET In 2025, healthcare stocks are catching the eye of investors, and it’s not just because of their role in our well-being. The sector’s potential for growth and innovation makes it an attractive option for those looking to diversify their portfolios. L...

2025-01-30 16:50:00 ET When evaluating growth stocks on the TSX in 2025, Canadian investors should focus on several key factors. A strong growth stock is one that demonstrates expanding revenue, solid profitability, and strategic initiatives that fuel future expansion. However, picking ...

2025-01-10 08:15:00 ET From established players to up-and-coming firms, Canada's pharmaceutical company landscape is diverse and dynamic. Canadian drug companies are working to discover and develop major innovations amidst an increasingly competitive global landscape. Rising technol...